PhRMA
NOVEMBER 30, 2022
Antimicrobial resistance (AMR) is a growing health crisis resulting in nearly 50,000 U.S. deaths each year and 1.27 million globally on an annual basis – higher than HIV/AIDS and malaria. To slow and control continued AMR, we need a robust pipeline of novel products, and at the same time we need to ensure they are used only in a limited set of circumstances and in only the most necessary cases.
Drug Topics
NOVEMBER 30, 2022
Results from a randomized controlled trial study suggest dextromethorphan may even worsen patient pain experience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 30, 2022
Challenges for uptake of long-acting injectable pre-exposure prophylaxis in populations at risk for HIV include fear of needles, potential adverse effects, and concerns about diminished efficacy.
Drug Topics
NOVEMBER 30, 2022
Many independent pharmacies closed during the last recession.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 30, 2022
Although it has received less attention as flu season begins, public health experts are continuing to urge vaccination against monkeypox.
STAT
NOVEMBER 30, 2022
Stanford University has opened an investigation into its president, Marc Tessier-Lavigne, a renowned neuroscientist and former biotech executive, for research misconduct after experts alleged papers on which he was an author included altered images, the university confirmed. The university’s board will oversee the investigation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 30, 2022
Elon Musk’s brain-machine interface company Neuralink aims to put its first implant in a human subject in the next six months, he said during an event Wednesday. Musk said the company has been “working hard to be ready for our first human,” and has submitted most of the required paperwork to the Food and Drug Administration to launch a study in humans.
Pharmacy Times
NOVEMBER 30, 2022
Expert panelists discuss potential coming developments in the treatment landscape for breast cancer.
STAT
NOVEMBER 30, 2022
The Food and Drug Administration approved the first therapy using bacteria from stool samples to treat a bowel disorder on Wednesday, paving the way for several similar treatments in development. The drug, called Rebyota, is given as a one-dose treatment for clostridium difficile infection s, commonly known as C. diff., in which the toxin-producing bacteria disrupts the normal balance in a person’s digestive system.
Pharmacy Times
NOVEMBER 30, 2022
Pharmacy Times will be covering the American Society of Health-System Pharmacists 2022 Midyear Clinical Meeting from December 4 to 8.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
NOVEMBER 30, 2022
The Food and Drug Administration on Wednesday ended its emergency authorization for the only remaining Covid-19 antibody therapy cleared for use, saying variants that render it ineffective are now dominant in the United States. The news about bebtelovimab makes official what has been anticipated for several weeks, as the Omicron sublineages BQ.1 and BQ.1.1 have been growing in prevalence.
Pharmacy Times
NOVEMBER 30, 2022
This months over-the-counter (OTC) product guide highlights products that contain natural ingredients.
STAT
NOVEMBER 30, 2022
In the spring of 1981, a geneticist from Indianapolis and a neurologist from Chicago got in a car and for three days they crisscrossed the yellowing cornfields of Iowa. Every now and then, they stopped at a house to draw blood from the inhabitants — more than 30 members of one extended family spread across the state. The scientists sent the blood 950 miles east to Massachusetts General Hospital in Boston, to a tiny lab (recently converted from a storeroom) where a 28-year-old postdoc name
Pharmacy Times
NOVEMBER 30, 2022
Adults with attachment anxiety were more likely to misremember facts when they could see the person speaking.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
NOVEMBER 30, 2022
New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add to the weight of allegations against him, according to experts on research misconduct. On Tuesday, Stanford announced an investigation into its president following allegations of altered images in four papers co-authored by Tessier-Lavigne over a seven-year period earlier in his research career.
Pharmaceutical Technology
NOVEMBER 30, 2022
Multiple sclerosis (MS) is an autoimmune disease causing chronic inflammation and demyelination of the nerves, affecting around 2.5 million people worldwide. While patients diagnosed with relapsing MS (RMS) have a wide range of marketed treatment options, patients diagnosed with progressive MS, especially primary progressive MS (PPMS), have very limited treatment options.
STAT
NOVEMBER 30, 2022
Cancer is becoming less deadly in America. According to the recently released Annual Report to the Nation on the Status of Cancer , overall cancer death rates have continued to decline by about 2% per year over the last several years for Americans of all ages, races, and genders. The decline in cancer death rates is clearly welcome news and coincides with a significant shift in cancer treatment through the development of new targeted therapies and accompanying diagnostic tests that guide their u
pharmaphorum
NOVEMBER 30, 2022
Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The Marriot Auditorium & Conference Centre was the venue for this occasion, the largest global conference of its kind in Europe, the titular space made clear just how ‘big’ these systems are in facilitating what pharma does, today and very much tomorrow.
STAT
NOVEMBER 30, 2022
The Covid-19 pandemic blew up budget deficits in low- and middle-income countries, pushing many toward or into precarious financial straits. There is also growing pressure on policymakers to soften the impact of food and energy inflation with temporary tax and tariff cuts and consumption subsidies, measures that will need to be offset by other fiscal responses to fill budget holes.
Fierce Healthcare
NOVEMBER 30, 2022
Amid 'tripledemic,' text-based pediatric care startup Summer Health extends free trials to parents. agliadkovskaya. Wed, 11/30/2022 - 15:30.
STAT
NOVEMBER 30, 2022
As the world watches the rare spectacle of protesters challenging China’s authoritarian leadership over its increasingly perplexing “zero Covid” policy, people who study the disease see threats ahead for China — and beyond. The zero Covid policy, which has kept cases and deaths in China to negligible numbers throughout the pandemic, seems doomed to fail in the face of the highly transmissible Omicron variant of the SARS-CoV-2 virus, they believe.
Fierce Healthcare
NOVEMBER 30, 2022
Mental health providers decry 'mind-numbing' prior authorization burdens as Senate debates reforms. rking. Wed, 11/30/2022 - 13:13.
STAT
NOVEMBER 30, 2022
New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add to the weight of allegations against him, according to experts on research misconduct. On Tuesday, Stanford announced an investigation into its president following allegations of altered images in four papers co-authored by Tessier-Lavigne over a seven-year period earlier in his research career.
Fierce Healthcare
NOVEMBER 30, 2022
How tech companies are using AI to tackle clinician burnout, administrative burdens. aburky. Wed, 11/30/2022 - 14:21.
STAT
NOVEMBER 30, 2022
With growing concern about the circulation of vaccine-derived polioviruses in the United States, the Centers for Disease Control and Prevention said Wednesday that it would work with select communities across the country to conduct wastewater surveillance for the viruses. The launch of the initiative follows the discovery over the summer of vaccine-derived polioviruses circulating in the sewage of a number of counties in and around New York City.
Drug Store News
NOVEMBER 30, 2022
To best address social determinants of health and improve the health of low-income. patients, start with pharmacists.
STAT
NOVEMBER 30, 2022
SAN FRANCISCO — The failure of a once-promising Alzheimer’s disease medicine from Roche appears to have a simple explanation: The drug didn’t do its job. In a presentation just weeks after Roche announced the drug’s failure , the Swiss pharma giant on Wednesday said its treatment had a disappointing effect on a toxic protein called amyloid, whose accumulation in the brain is thought to drive the advance of Alzheimer’s.
Fierce Healthcare
NOVEMBER 30, 2022
Texas hospitals warn of rural closures, care delays and service cuts without legislative support. dmuoio. Wed, 11/30/2022 - 16:50.
STAT
NOVEMBER 30, 2022
Electronic health records don’t leave much room for nuance: On paper, two patients with the same type of knee problem might score the same on a standardized walking test, and have tried the same treatment options. But once they walk out of the clinic, the same condition could impact each of their lives in considerably different ways. “If disability is an interaction between a person’s health condition, and their environment, and the personal choices they make, we’ve g
Drug Store News
NOVEMBER 30, 2022
Upon the completion of a transition services agreement, Biocon Biologics will assume responsibility for commercial, regulatory and other related services.
European Pharmaceutical Review
NOVEMBER 30, 2022
Full study results on Eisai’s pivotal Phase III Alzheimer’s (AD) trial for lecanemab, an anti-amyloid beta (A?) protofibril antibody , suggest that the drug could slow the rate of disease progression by 2.5-3.1 years and help people remain in the earlier stages of the disease for longer. The data has been published in The New England Journal of Medicine (NEJM) and was presented at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference in the US.
Pharmacy Times
NOVEMBER 30, 2022
The 2022 theme is “Putting Ourselves to the Test: Achieving Equity to End HIV.”.
Drug Store News
NOVEMBER 30, 2022
Mod Vanilla and Mod Blush fragrances were inspired by the modernity, freedom of expression and individuality of the 1960s London subculture.
Fierce Healthcare
NOVEMBER 30, 2022
Study comparing surgical masks to N95s stirs controversy. fdiamond. Wed, 11/30/2022 - 15:58.
Expert insights. Personalized for you.
214 
Let's personalize your content